Angiogenic signature of multiple myeloma determined by gene expression profiling

被引:0
|
作者
Hose, Dirk [1 ,6 ]
Moreaux, Jerome [2 ]
Meissner, Tobias [1 ,3 ]
Rossi, Jean-Francois [2 ]
Benner, Axel [3 ]
Mahtouk, Karene [2 ]
Seckinger, Anja [1 ]
Heiss, Christiane [3 ]
Hundemer, Michael [1 ]
Reme, Thierry [2 ]
Hillengass, Jens [1 ]
Herde, Katja [5 ]
Bertsch, Uta
DeVos, John [2 ]
Wenisch, Sabine
Pantesco, Veronique [2 ]
Jauch, Anna [4 ]
Jourdan, Eric [2 ]
Goldschmidt, Hartmut [6 ]
Klein, Bernard
Moehler, Thomas [6 ]
机构
[1] Univ Hosp Heidelberg, Heidelberg, Germany
[2] CHU Montpellier, INSERM, U475, Montpellier, France
[3] German Canc Res Ctr, D-6900 Heidelberg, Germany
[4] Univ Hosp Heidelberg, Inst Human Genet, Heidelberg, Germany
[5] Expt Surg Lab, Giessen, Germany
[6] Natl Ctr Tumor Dis, Heidelberg, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2484
引用
收藏
页码:732A / 733A
页数:2
相关论文
共 50 条
  • [41] Gene expression profiling of multiple myeloma reveals molecular portraits in relation to the pathogenesis of the disease
    Magrangeas, F
    Nasser, V
    Avet-Loiseau, H
    Loriod, B
    Decaux, O
    Granjeaud, S
    Bertucci, F
    Birnbaum, D
    Nguyen, C
    Harousseau, JL
    Bataille, R
    Houlgatte, F
    Minvielle, S
    BLOOD, 2003, 101 (12) : 4998 - 5006
  • [42] Gene Expression Profiling in Multiple Myeloma: Redefining the Paradigm of Risk-Adapted Treatment
    Cerchione, Claudio
    Usmani, Saad Z.
    Stewart, A. Keith
    Kaiser, Martin
    Rasche, Leo
    Kortuem, Martin
    Mateos, Maria-Victoria
    Spencer, Andrew
    Sonneveld, Pieter
    Anderson, Kenneth C.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [43] A gene expression signature for high-risk multiple myeloma (vol 28, 1178, 2014)
    Kuiper, R.
    Broyl, A.
    de Knegt, Y.
    van Vliet, M. H.
    van Beers, E. H.
    van der Holt, B.
    el Jarari, L.
    Mulligan, G.
    Gregory, W.
    Morgan, G.
    Goldschmidt, H.
    Lokhorst, H. M.
    van Duin, M.
    Sonneveld, P.
    LEUKEMIA, 2014, 28 (05) : 1178 - 1180
  • [44] Expression of PRAME gene in multiple myeloma
    Abramenko, IB
    Belous, NI
    Kryachok, IA
    Chumak, AA
    Aksenova, EV
    Lisovskaya, EV
    Misyurin, AV
    TERAPEVTICHESKII ARKHIV, 2004, 76 (07) : 77 - 81
  • [45] A validated gene expression signature of high risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome
    Shaughnessy, John D., Jr.
    Zhan, Fenghuang
    Burington, Bart
    Huang, Yongsheng
    Hanamura, Ichiro
    Stewart, James P.
    Hollmig, Klaus
    Pineda-Roman, Mauricio
    Tricot, Guido
    van Rhee, Frits
    Zangari, Maurizio
    Crowley, John
    Barlogie, Bart
    BLOOD, 2006, 108 (11) : 37A - 37A
  • [46] Expression profiling of signature gene sets with trinucleotide threading
    Zajac, Pawel
    Pettersson, Erik
    Gry, Marcus
    Lundeberg, Joakim
    Ahmadian, Afshin
    GENOMICS, 2008, 91 (02) : 209 - 217
  • [47] Multiple sclerosis and gene expression profiling
    Steinman, L
    MECHANISMS OF LYMPHOCYTE ACTIVATION AND IMMUNE REGULATION VIII: AUTOIMMUNITY 2000 AND BEYOND, 2001, 490 : 109 - 112
  • [48] Gene Expression Profiling in Multiple Myeloma-Reporting of Entities, Risk, and Targets in Clinical Routine
    Meissner, Tobias
    Seckinger, Anja
    Reme, Thierry
    Hielscher, Thomas
    Moehler, Thomas
    Neben, Kai
    Goldschmidt, Hartmut
    Klein, Bernard
    Hose, Dirk
    CLINICAL CANCER RESEARCH, 2011, 17 (23) : 7240 - 7247
  • [49] Gene Expression Profiling of Kinetic Response to Proteasome Inhibitors in Innate and Acquired Resistant Multiple Myeloma
    Mitra, Amit Kumar
    Ramakrishnan, Vijay G.
    Kumar, Shaji K.
    Rajkumar, S. Vincent
    Van Ness, Brian G.
    BLOOD, 2017, 130
  • [50] Molecular profiling of multiple myeloma: from gene expression analysis to next-generation sequencing
    Agnelli, Luca
    Tassone, Pierfrancesco
    Neri, Antonino
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 : S55 - S68